Leveraging AQbD Principles for Development of Challenging Drug Substance Stability-Indicating Methods

[1]  Marion J. Chatfield,et al.  Using the Analytical Target Profile to Drive the Analytical Method Lifecycle. , 2019, Analytical chemistry.

[2]  I. Molnár,et al.  Quality by Design: Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. , 2012, Journal of chromatography. A.

[3]  D. Guillarme,et al.  Computer‐assisted UHPLC–MS method development and optimization for the determination of 24 antineoplastic drugs used in hospital pharmacy , 2019, Journal of pharmaceutical and biomedical analysis.

[4]  B. Mann,et al.  In silico method development for the reversed-phase liquid chromatography separation of proteins using chaotropic mobile phase modifiers. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Jun Li,et al.  Current complexity: a tool for assessing the complexity of organic molecules. , 2015, Organic & biomolecular chemistry.

[6]  John J. Venit,et al.  A 21st Century HPLC Workflow for Process R&D , 2005 .

[7]  B. Mann,et al.  Introducing multifactorial peak crossover in analytical and preparative chromatography via computer-assisted modeling. , 2020, Analytical chemistry.

[8]  Bruno Boulanger,et al.  Analytical Procedure Validation and the Quality by Design Paradigm , 2015, Journal of biopharmaceutical statistics.

[9]  P. Haddad,et al.  Computer-assisted multi-segment gradient optimization in ion chromatography. , 2015, Journal of chromatography. A.

[10]  I. Molnár,et al.  Automated UHPLC separation of 10 pharmaceutical compounds using software‐modeling , 2018, Journal of pharmaceutical and biomedical analysis.

[11]  Tim Tome,et al.  Development and Optimization of Liquid Chromatography Analytical Methods by Using AQbD Principles: Overview and Recent Advances , 2019, Organic Process Research & Development.

[12]  Marion J. Chatfield,et al.  Method ruggedness studies incorporating a risk based approach: a tutorial. , 2011, Analytica chimica acta.

[13]  Michael A. Schmidt,et al.  On the design of complex drug candidate syntheses in the pharmaceutical industry , 2017 .

[14]  D. Guillarme,et al.  The Emergence of Universal Chromatographic Methods in the Research and Development of New Drug Substances. , 2019, Accounts of chemical research.

[15]  Christopher J. Welch,et al.  Current challenges and future prospects in chromatographic method development for pharmaceutical research , 2017 .

[16]  J. Veuthey,et al.  Recent Advances in Chromatography for Pharmaceutical Analysis. , 2018, Analytical chemistry.

[17]  Jimmy O. DaSilva,et al.  Mapping the Separation Landscape of Pharmaceuticals: Rapid and Efficient Scale-Up of Preparative Purifications Enabled by Computer-Assisted Chromatographic Method Development , 2019, Organic Process Research & Development.

[18]  P. Carr,et al.  Role of ion pairing in anionic additive effects on the separation of cationic drugs in reversed-phase liquid chromatography. , 2005, Journal of chromatography. A.

[19]  E. Regalado,et al.  Multi-column ultra-high performance liquid chromatography screening with chaotropic agents and computer-assisted separation modeling enables process development of new drug substances. , 2019, The Analyst.